FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2076249810> ?p ?o ?g. }

• W2076249810 endingPage "251" @default.
• W2076249810 startingPage "244" @default.
• W2076249810 abstract "Non-alcoholic fatty liver disease (NAFLD) is a frequent kind of metabolic syndrome, which included a wide spectrum of liver damage and closely associated with insulin resistance and other metabolic syndromes such as obesity, type II diabetes, hyperglycemia, etc. Recently, a new series of PPARγ ligands based on barbituric acid has been designed, in which 5-(4-(benzyloxy)benzylidene)pyrimidine-2,4,6(1H,3H,5H)-trione (SKLB102) showed a high affinity with PPARγ. The current study aimed to evaluate the protective effect of SKLB102 on NAFLD and investigate the underlying mechanisms. In vivo, oral administration of SKLB102 prevented the pathological development, as demonstrated by reducing liver weight and visceral fat effectively, decreasing the serum levels of alanine transaminase, TNF-α and glucose, diminishing the hepatic triglyceride and malondialdehyde content and recovering the abnormal down-regulation of LDL. Histological examination of liver sections by Oil Red O and H&E staining confirmed the protective effect of SKLB102 on NAFLD. Furthermore, SKLB102 elevated the serum level of adiponectin, reduced the serum level of leptin and prevented insulin resistance. Western blots indicated that SKLB102 increased the hepatic AMPK activities and CPT-1 expression. In vitro, SKLB102 showed the ability of significantly enhancing adiponectin expression and inhibiting leptin expression in 3T3-L1 adipocytes. Furthermore, SKLB102 could promote glucose consumption in HepG2 cells in the presence of 0.1 μM insulin. In conclusion, our current study provided strong evidence that SKLB102 had potent ability to reduce fat deposition and protect liver against NAFLD through regulating adipocytokine expression and preventing insulin resistance, which might be of protective value for the prevention of NAFLD." @default.
• W2076249810 created "2016-06-24" @default.
• W2076249810 creator A5007253061 @default.
• W2076249810 creator A5013936797 @default.
• W2076249810 creator A5015968141 @default.
• W2076249810 creator A5029538972 @default.
• W2076249810 creator A5040600394 @default.
• W2076249810 creator A5041349591 @default.
• W2076249810 creator A5066904286 @default.
• W2076249810 creator A5068908330 @default.
• W2076249810 creator A5074149482 @default.
• W2076249810 creator A5083786888 @default.
• W2076249810 date "2011-06-01" @default.
• W2076249810 modified "2023-10-18" @default.
• W2076249810 title "A novel agonist of PPAR-γ based on barbituric acid alleviates the development of non-alcoholic fatty liver disease by regulating adipocytokine expression and preventing insulin resistance" @default.
• W2076249810 cites W1587875569 @default.
• W2076249810 cites W1968805253 @default.
• W2076249810 cites W1971827509 @default.
• W2076249810 cites W1979560727 @default.
• W2076249810 cites W1980386483 @default.
• W2076249810 cites W1983417944 @default.
• W2076249810 cites W1989494032 @default.
• W2076249810 cites W1990055069 @default.
• W2076249810 cites W2006803531 @default.
• W2076249810 cites W2011605334 @default.
• W2076249810 cites W2012547073 @default.
• W2076249810 cites W2016293185 @default.
• W2076249810 cites W2018150911 @default.
• W2076249810 cites W2019280401 @default.
• W2076249810 cites W2019664894 @default.
• W2076249810 cites W2023722762 @default.
• W2076249810 cites W2025347049 @default.
• W2076249810 cites W2034585835 @default.
• W2076249810 cites W2040109162 @default.
• W2076249810 cites W2042706232 @default.
• W2076249810 cites W2043462108 @default.
• W2076249810 cites W2050360984 @default.
• W2076249810 cites W2067416779 @default.
• W2076249810 cites W2079348671 @default.
• W2076249810 cites W2080348345 @default.
• W2076249810 cites W2097794068 @default.
• W2076249810 cites W2120688902 @default.
• W2076249810 cites W2122563474 @default.
• W2076249810 cites W2123205520 @default.
• W2076249810 cites W2127934772 @default.
• W2076249810 cites W2132503406 @default.
• W2076249810 cites W2142153422 @default.
• W2076249810 cites W2142415239 @default.
• W2076249810 cites W2144178804 @default.
• W2076249810 cites W2156116850 @default.
• W2076249810 cites W2157379232 @default.
• W2076249810 cites W2165103770 @default.
• W2076249810 cites W2185491274 @default.
• W2076249810 cites W4237813261 @default.
• W2076249810 cites W4240449862 @default.
• W2076249810 doi "https://doi.org/10.1016/j.ejphar.2011.03.033" @default.
• W2076249810 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21463618" @default.
• W2076249810 hasPublicationYear "2011" @default.
• W2076249810 type Work @default.
• W2076249810 sameAs 2076249810 @default.
• W2076249810 citedByCount "30" @default.
• W2076249810 countsByYear W20762498102012 @default.
• W2076249810 countsByYear W20762498102013 @default.
• W2076249810 countsByYear W20762498102014 @default.
• W2076249810 countsByYear W20762498102015 @default.
• W2076249810 countsByYear W20762498102016 @default.
• W2076249810 countsByYear W20762498102017 @default.
• W2076249810 countsByYear W20762498102018 @default.
• W2076249810 countsByYear W20762498102019 @default.
• W2076249810 countsByYear W20762498102020 @default.
• W2076249810 countsByYear W20762498102021 @default.
• W2076249810 countsByYear W20762498102022 @default.
• W2076249810 countsByYear W20762498102023 @default.
• W2076249810 crossrefType "journal-article" @default.
• W2076249810 hasAuthorship W2076249810A5007253061 @default.
• W2076249810 hasAuthorship W2076249810A5013936797 @default.
• W2076249810 hasAuthorship W2076249810A5015968141 @default.
• W2076249810 hasAuthorship W2076249810A5029538972 @default.
• W2076249810 hasAuthorship W2076249810A5040600394 @default.
• W2076249810 hasAuthorship W2076249810A5041349591 @default.
• W2076249810 hasAuthorship W2076249810A5066904286 @default.
• W2076249810 hasAuthorship W2076249810A5068908330 @default.
• W2076249810 hasAuthorship W2076249810A5074149482 @default.
• W2076249810 hasAuthorship W2076249810A5083786888 @default.
• W2076249810 hasConcept C126322002 @default.
• W2076249810 hasConcept C134018914 @default.
• W2076249810 hasConcept C2776782570 @default.
• W2076249810 hasConcept C2777391703 @default.
• W2076249810 hasConcept C2778163477 @default.
• W2076249810 hasConcept C2778772119 @default.
• W2076249810 hasConcept C2778913445 @default.
• W2076249810 hasConcept C2779134260 @default.
• W2076249810 hasConcept C2779306644 @default.
• W2076249810 hasConcept C2780578515 @default.
• W2076249810 hasConcept C2780613262 @default.
• W2076249810 hasConcept C511355011 @default.
• W2076249810 hasConcept C555293320 @default.
• W2076249810 hasConcept C71924100 @default.

• next